Insider Selling: Mannatech, Incorporated (NASDAQ:MTEX) Director Sells $126,232.00 in Stock

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Mannatech Price Performance

NASDAQ MTEX opened at $7.57 on Friday. The firm’s 50 day moving average price is $7.29 and its two-hundred day moving average price is $7.78. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54. Mannatech, Incorporated has a twelve month low of $6.75 and a twelve month high of $12.75.

Mannatech (NASDAQ:MTEXGet Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The business had revenue of $27.74 million for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of Mannatech in a research note on Saturday, September 7th. They set a “buy” rating for the company.

Check Out Our Latest Report on Mannatech

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Stories

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.